You are here: All Products  > CStone Reports China to Review NDA for RET Inhibitor in Thyroid Cancer

CStone Reports China to Review NDA for RET Inhibitor in Thyroid Cancer

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products